A5059960559- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Prostate Cancer Treatment and Research
- Radiopharmaceutical Chemistry and Applications
- Bariatric Surgery and Outcomes
- Peptidase Inhibition and Analysis
- Congenital Heart Disease Studies
- Sarcoidosis and Beryllium Toxicity Research
- Mycobacterium research and diagnosis
- Orthopedic Infections and Treatments
- Metabolism, Diabetes, and Cancer
- Tracheal and airway disorders
- Hepatocellular Carcinoma Treatment and Prognosis
- Prostate Cancer Diagnosis and Treatment
- Diet and metabolism studies
- Problem and Project Based Learning
- Lymphadenopathy Diagnosis and Analysis
- Alcoholism and Thiamine Deficiency
- Pneumocystis jirovecii pneumonia detection and treatment
- Infectious Diseases and Tuberculosis
- Lung Cancer Treatments and Mutations
- Neurological and metabolic disorders
- Parkinson's Disease Mechanisms and Treatments
- Cardiac Structural Anomalies and Repair
- COVID-19 and healthcare impacts
University of Massachusetts Chan Medical School
2024
Brigham and Women's Hospital
2022-2023
Beth Israel Deaconess Medical Center
2013-2019
Harvard University
2019
Society of Nuclear Medicine and Molecular Imaging
2014
Universitat Autònoma de Barcelona
2012-2014
Vall d'Hebron Institut de Recerca
2012
Identification of cancer or inflammatory bowel disease in the intestinal tract by PET/computed tomography (CT) imaging can be hampered physiological uptake F-fluorodeoxyglucose (F-FDG) normal colon. Previous work has localized this F-FDG to lumen, predominantly occupied bacteria. We sought determine whether pretreatment with an antibiotic could reduce healthy colon.Thirty patients undergoing restaging PET/CT for nongastrointestinal lymphoma were randomly selected receive rifaximin 550 mg...
PET/CT is a commonly used modality in cancer imaging, as it can help diagnosis, staging and assessment of treatment response many types. A better understanding the tumor microenvironment identification multiple selective targets are promoting further investigation into different radiotracers for diagnosis therapy. In past few decades radiopharmaceuticals have emerged specific oncologic indications providing superior detection rate than some morphologic modalities. The purpose this review to...
Additional Supporting Information may be found in the online version of this article. Please note: The publisher is not responsible for content or functionality any supporting information supplied by authors. Any queries (other than missing content) should directed to corresponding author